Latest KFF Health News Stories
Readers and Tweeters Take Positions on Sleep Apnea Treatment
KHN gives readers a chance to comment on a recent batch of stories.
$38,398 for a Single Shot of a Very Old Cancer Drug
Lupron, a drug patented half a century ago, treats advanced prostate cancer. It’s sold to physicians for $260 in the U.K. and administered at no charge. Why are U.S. hospitals — which may pay nearly as little for the drug — charging so much more to administer it?
KHN’s ‘What the Health?’: Biden Hits the Road to Sell Democrats’ Record
With the midterm elections rapidly approaching, President Joe Biden has taken to the road to convince voters that he and congressional Democrats have delivered for them during two years in power. Among the health issues highlighted by the administration this week are pandemic preparedness and the availability of over-the-counter hearing aids. The president also promised to sign a bill codifying the abortion protections of Roe v. Wade if Democrats maintain control of the House and Senate — even though it’s a long shot that there will be enough votes for that. Sarah Karlin-Smith of the Pink Sheet, Sandhya Raman of CQ Roll Call, and Mary Agnes Carey of KHN join KHN’s Julie Rovner to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
El vínculo con la esclerosis múltiple impulsa una vacuna contra el virus Epstein-Barr
Los científicos llevan años intentando desarrollar vacunas contra este virus. Sin embargo, recientemente varios avances en la investigación médica han dado más urgencia a la búsqueda y más esperanzas de éxito.
As Links to MS Deepen, Researchers Accelerate Efforts to Develop an Epstein-Barr Vaccine
Recent leaps in medical research have lent urgency to the quest to develop a vaccine against Epstein-Barr, a ubiquitous virus that has been linked to a range of illnesses, from mononucleosis to multiple sclerosis and several cancers.
La nueva generación de medicamentos para la pérdida de peso es prometedora, pero tiene un precio
Algunos pacientes, según los especialistas en medicina de la obesidad, experimentan una disminución de la presión arterial, un mejor control de la diabetes, menos dolor en las articulaciones y un mejor sueño gracias a estos nuevos tratamientos.
New Generation of Weight Loss Medications Offer Promise — But at a Price
People now have at their disposal more medicines that are effective at reducing weight, but none can counter obesity alone. One big problem: Insurance coverage remains spotty, and the costly drugs may be needed long term.
Severe Sleep Apnea Diagnosis Panics Reporter Until He Finds a Simple, No-Cost Solution
An industry has grown up around sleep apnea, stirring concerns about overdiagnosis and overtreatment.
Pharma-Funded FDA Gets Drugs Out Faster, But Some Work Only ‘Marginally’ and Most Are Pricey
Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.
KHN’s ‘What the Health?’: On Government Spending, Congress Decides Not to Decide
Congress has once again decided not to decide how to fund the federal government in time for the start of the fiscal year, racing toward a midnight Sept. 30 deadline to pass a stopgap bill that would keep the lights on for two more months. However, it does appear the FDA’s program that gets drugmakers to help fund some of the agency’s review staff will be renewed in time to stop pink slips from being sent. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Victoria Knight of Axios join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews filmmaker Cynthia Lowen, whose new documentary, “Battleground,” explores how anti-abortion forces played the long game to overturn Roe v. Wade.
Readers and Tweeters Take a Close Look at Eye Care and White Mulberry Leaf
KHN gives readers a chance to comment on a recent batch of stories.
Centene Agrees to Pay Massachusetts $14 Million Over Medicaid Prescription Claims
Massachusetts is the latest state to settle with St. Louis-based Centene Corp. over allegations that it overcharged Medicaid prescription drug programs.
Médicos se apresuran a usar fallo de la Corte Suprema para liberarse de cargos por opioides
En una decisión de junio, el tribunal dijo que los fiscales no solo deben probar que una receta no estaba médicamente justificada sino también que el que la escribió sabía del riesgo de recetar opioides.
Doctors Rush to Use Supreme Court Ruling to Escape Opioid Charges
After a unanimous ruling from the high court, doctors who are accused of writing irresponsible prescriptions can go to trial with a new defense: It wasn’t on purpose.
Court Ruling May Spur Competitive Health Plans to Bring Back Copays for Preventive Services
The Affordable Care Act required that health insurers provide many medical screenings and prevention services at no out-of-pocket cost to health plan members. But insurers and employers may consider adding cost sharing for preventive services now that a federal court ruled the ACA’s mandate is unconstitutional.
California y Nueva York buscan frenar la venta de píldoras para adelgazar a menores
Si ambas medidas se convierten en ley, sus defensores esperan que den impulso a la restricción de la venta de píldoras dietéticas a niños y adolescentes en más estados.
California and New York Aim to Curb Diet Pill Sales to Minors
California and New York would be the first states to require anyone under 18 to obtain prescriptions to purchase over-the-counter weight loss products, which some research has linked to eating disorders.
‘An Arm and a Leg’: The New Cap on Medicare Drug Costs
In this episode, Julie Rovner, chief Washington correspondent for KHN, guides listeners through decades of dealings between Congress and Big Pharma.
Did the US Jump the Gun With the New Omicron-Targeted Vaccines?
With fears of a winter surge looming, government agencies have authorized and encouraged vaccination with a newly formulated booster. But the science to support that decision remains inconclusive.
Readers and Tweeters Place Value on Community Services and Life-Sustaining Care
KHN gives readers a chance to comment on a recent batch of stories.
